Sort
85,873 grants matching “alzheimers”
Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework
$2,561,961Ann D. Cohen · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimerâs disease pathogenesis in the BEACoN Cohort
$2,561,798Michael A Yassa · University Of California-Irvine · R01 · FY2023 · AG
Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health
$2,561,480Hui Hu · Brigham And Women'S Hospital · RF1 · FY2023 · AG
CORE B-Data Management, Harmonization, and Information Transfer Core
$2,560,381Li-San Wang · University Of Pennsylvania · U54 · FY2023 · AG
A double-blinded, randomized, controlled phase 2a safety, proof-of-concept and exploratory end point trial of the drug LM11A-31 in patients with mild to moderate Alzheimer's disease.
$2,559,183Manfred Windisch · Pharmatrophix, Inc. · R01 · FY2019 · AG
Clinical Core
$2,557,564Rhoda Au · Boston University Medical Campus · U19 · FY2022 · AG
Molecular mechanisms of calcification: roles and opportunities in diseases of aging
$2,556,214Francesca M Marassi · Medical College Of Wisconsin · P01 · FY2025 · AG
Modeling Alzheimer's Disease Related Dementias in the Marmoset
$2,556,211Kuo-Fen Lee · Salk Institute For Biological Studies · R61 · FY2019 · NS
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
$2,555,846Hui Zheng · Baylor College Of Medicine · P01 · FY2025 · AG
Regulation of ER-stress Activated UPR kinase PERK in Neurodegenerative Diseases
$2,555,390James D Lechleiter · University Of Texas Hlth Science Center · RF1 · FY2019 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,553,933John Morris · Washington University · P50 · FY2014 · AG
Genetic Studies of Alzheimer's Disease in Caribbean Hispanics
$2,553,177Richard Mayeux · Columbia University Health Sciences · RF1 · FY2015 · AG
SBIR - TOPIC 009 - AI/ML TOOL FOR VISUALIZING BEHAVIORAL AND SOCIAL SCIENCE RESEARCH
$2,549,818Gratiana Pol · Hyperthesis, Llc · N43 · FY2024 · DA
Advancing Diagnosis of Dementia in Primary Care Practice(ADDPCP)
$2,549,563Howard J Rosen · University Of California, San Francisco · R01 · FY2025 · AG
The Four Repeat Tauopathy Neuroimaging Initiative
$2,549,244Adam L Boxer · University Of California, San Francisco · R01 · FY2020 · AG
Structural Markers for Alzheimer's Disease and Cerebral Amyloid Angiopathy
$2,548,256Steven Owen Smith · State University New York Stony Brook · RF1 · FY2016 · AG
Novel Imaging and Biofluid Biomarkers of Small Vessel Cerebrovascular Disease
$2,547,585Joel H Kramer · University Of California, San Francisco · UF1 · FY2021 · NS
Alzheimer's Disease Research Center
$2,546,891Murray A Raskind · University Of Washington · P50 · FY2009 · AG
Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimerâs disease pathogenesis in the BEACoN Cohort
$2,544,663Michael A Yassa · University Of California-Irvine · R01 · FY2024 · AG
An ultra-long-acting oral treatment for opioid use disorder
$2,543,976Andrew Martin Bellinger · Lyndra Therapeutics, Inc. · UG3 · FY2018 · DA
Clinical Core
$2,542,714Rhoda Au · Boston University Medical Campus · U19 · FY2023 · AG
Cognate microglia-neuron interaction and its role in inflammation
$2,542,500Anne Schaefer · Icahn School Of Medicine At Mount Sinai · DP2 · FY2012 · MH
Bridging the gap from genes to circuits to behavior in understanding cognitive dysfunction
$2,542,500Priya Rajasethupathy · Rockefeller University · DP2 · FY2017 · AG
How does the brain maximize storage capacity?
$2,542,497Denise Jade Cai · Icahn School Of Medicine At Mount Sinai · DP2 · FY2019 · MH
Multicultural Community Dementia Screening
$2,541,385James E Galvin · University Of Miami School Of Medicine · R01 · FY2025 · AG